Isoniazid/Rifampicin

异烟肼/利福平

Report date: 2023/01/13 20:00:32

Base Information

Drug NameIsoniazid/Rifampicin
Drug Alias Name利福平/异烟肼Rifampicin/Isoniazid异福片rifampicin and isoniazidIsoniazid and Rifampicin +[7] 
ClassificationSmall molecules
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsTuberculosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved DateN/A
Country/TerritorySingaporeUnited KingdomMainland China
CombinationsYes RifampicinIsoniazid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesPfizer Inc
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeJ04AM02
Related LinksN/A